InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| FLA-ST (Standard or Ultrapure) | A new acid isolated from V. negundo L. inhibits NLRP3 inflammasome activation... | 2023 | Front Immunol. | Di Q. et al. | DOI: 10.3389/fimmu.2023.1174463 |
| Nigericin | A new acid isolated from V. negundo L. inhibits NLRP3 inflammasome activation... | 2023 | Front Immunol. | Di Q. et al. | DOI: 10.3389/fimmu.2023.1174463 |
| ODN 2216 - TLR9 ligand | Differential immunophenotype of circulating monocytes from pregnant women in ... | 2023 | BMC Pregnancy Childbirth | Farias-Jofre M. et al. | DOI: 10.1186/s12884-023-05562-0 |
| R848 VacciGrade™ | Differential immunophenotype of circulating monocytes from pregnant women in ... | 2023 | BMC Pregnancy Childbirth | Farias-Jofre M. et al. | DOI: 10.1186/s12884-023-05562-0 |
| Gardiquimod™ | Differential immunophenotype of circulating monocytes from pregnant women in ... | 2023 | BMC Pregnancy Childbirth | Farias-Jofre M. et al. | DOI: 10.1186/s12884-023-05562-0 |
| Poly(I:C) (HMW) VacciGrade™ | Differential immunophenotype of circulating monocytes from pregnant women in ... | 2023 | BMC Pregnancy Childbirth | Farias-Jofre M. et al. | DOI: 10.1186/s12884-023-05562-0 |
| Poly(I:C) (HMW) / LyoVec™ | Differential immunophenotype of circulating monocytes from pregnant women in ... | 2023 | BMC Pregnancy Childbirth | Farias-Jofre M. et al. | DOI: 10.1186/s12884-023-05562-0 |
| 2'3'-cGAMP | SEL1L–HRD1 endoplasmic reticulum-associated degradation controls STING-mediat... | 2023 | Nat Cell Biol. | Ji Y. et al. | DOI: 10.1038/s41556-023-01138-4 |
| STING inhibitor | SEL1L–HRD1 endoplasmic reticulum-associated degradation controls STING-mediat... | 2023 | Nat Cell Biol. | Ji Y. et al. | DOI: 10.1038/s41556-023-01138-4 |
| c-di-AMP | SEL1L–HRD1 endoplasmic reticulum-associated degradation controls STING-mediat... | 2023 | Nat Cell Biol. | Ji Y. et al. | DOI: 10.1038/s41556-023-01138-4 |
| Pam3CSK4 | SEL1L–HRD1 endoplasmic reticulum-associated degradation controls STING-mediat... | 2023 | Nat Cell Biol. | Ji Y. et al. | DOI: 10.1038/s41556-023-01138-4 |
| Poly(I:C) HMW | SEL1L–HRD1 endoplasmic reticulum-associated degradation controls STING-mediat... | 2023 | Nat Cell Biol. | Ji Y. et al. | DOI: 10.1038/s41556-023-01138-4 |
| Primocin® | Autofluorescence imaging permits label-free cell type assignment and reveals ... | 2023 | Elife | Shah V.S. et al. | DOI: 10.7554/eLife.84375 |
| Puromycin | Curcumin reduces paclitaxel resistance in ovarian carcinoma cells by upregula... | 2023 | Biochem Pharmacol. | Huang S.L. et al. | DOI: 10.1016/j.bcp.2023.115581 |
| LPS-B5 (LPS from E. coli O55:B5) | Impacts of plasma microbial lipopolysaccharide translocation on B cell pertur... | 2023 | Cell Biosci. | Fu X. et al. | DOI: 10.1186/s13578-023-01022-6 |
| ODN 2006 (ODN 7909) | Impacts of plasma microbial lipopolysaccharide translocation on B cell pertur... | 2023 | Cell Biosci. | Fu X. et al. | DOI: 10.1186/s13578-023-01022-6 |
| CR3022-derived Anti-SARS-CoV2 RBD mAbs, human & mouse isotypes | Intranasal administration of convalescent plasma protects against SARS-CoV-2 ... | 2023 | EBioMedicine | Wouters E. et al. | DOI: 10.1016/j.ebiom.2023.104597 |
| LPS-EB (LPS from E. coli O111:B4) | Extracellular vesicles released by hair follicle and adipose mesenchymal stro... | 2023 | Cytotherapy | Hernando S. et al. | DOI: 10.1016/j.jcyt.2023.04.001 |
| THP1-Blue™ NF-κB Cells | Divya-WeightGo combined with moderate aerobic exercise remediates adiposopath... | 2023 | Biomed Pharmacother. | Balkrishna A. et al. | DOI: 10.1016/j.biopha.2023.114785 |
| QUANTI-Blue™ | Divya-WeightGo combined with moderate aerobic exercise remediates adiposopath... | 2023 | Biomed Pharmacother. | Balkrishna A. et al. | DOI: 10.1016/j.biopha.2023.114785 |